Contrave vs. Phentermine For Weight Loss: What’s The Difference?

Contrave and phentermine are weight loss medications approved by the U.S. Food and Drug Administration (FDA) for adults with ...

CagriSema vs Tirzepatide For Weight Loss: What’s The Difference?

Tirzepatide is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) dual receptor agonist ...
Hosted on MSN

Tesamorelin studies show targeted visceral fat loss

Controlled clinical trials have shown tesamorelin, a growth hormone–releasing hormone analog, can significantly cut visceral fat while sparing subcutaneous fat. The effect has been replicated in ...

Doctor issues serious warning over 'most powerful' weight-loss jab as fears it's becoming 'new steroids' grow

Doctors are concerned about the new wave of weight-loss jabs and the risks they pose ...

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while ...

Company announcement No. 21 / 2026Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and ...